BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2643079)

  • 1. [Factors influencing hematopoiesis--a new therapeutic alternative?].
    Austgulen R
    Nord Med; 1989; 104(1):16-7. PubMed ID: 2643079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applications of recombinant human colony-stimulating factors.
    Klingemann HG
    CMAJ; 1989 Jan; 140(2):137-42. PubMed ID: 2642725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-CSF and GM-CSF in clinical trials.
    Antman KH
    Yale J Biol Med; 1990; 63(5):387-410. PubMed ID: 1705737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human recombinant derived IL-3 and GM-CSF in hematopoiesis of normal cynomolgus monkeys.
    Krumwieh D; Weinmann E; Seiler FR
    Behring Inst Mitt; 1988 Aug; (83):250-7. PubMed ID: 3071338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum colony stimulating factors in patients undergoing bone marrow transplantation: enhancing effect of recombinant human GM-CSF.
    Geissler D; Niederwieser D; Aulitzky WE; Tilg H; Grünewald K; Huber C; Konwalinka G
    Behring Inst Mitt; 1988 Aug; (83):289-300. PubMed ID: 3071343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF.
    Donahue RE; Wang EA; Stone DK; Kamen R; Wong GG; Sehgal PK; Nathan DG; Clark SC
    Nature; 1986 Jun 26-Jul 2; 321(6073):872-5. PubMed ID: 3487734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.
    Broxmeyer HE; Lu L; Cooper S; Tushinski R; Mochizuki D; Rubin BY; Gillis S; Williams DE
    J Immunol; 1988 Dec; 141(11):3852-62. PubMed ID: 3053902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical role of granulocyte-macrophage colony-stimulating factor.
    Mitsuyasu RT; Golde DW
    Hematol Oncol Clin North Am; 1989 Sep; 3(3):411-25. PubMed ID: 2698875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction and overview of hematopoietic growth factors.
    Gabrilove JL
    Semin Hematol; 1989 Apr; 26(2 Suppl 2):1-4. PubMed ID: 2658099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of murine hematopoiesis in vivo with recombinant murine interleukin-1.
    Gallicchio VS; Shedlofsky SI; Swim AT; Robinson JM; Hulette BC; Messino MJ; Doukas MA
    J Biol Response Mod; 1989 Aug; 8(4):422-39. PubMed ID: 2666587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
    Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of granulocyte-macrophage colony stimulating factor in patients with HIV infection.
    Mitsuyasu RT; Golde DW
    Behring Inst Mitt; 1988 Aug; (83):139-44. PubMed ID: 3071329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSFs, from basic science to clinical trials.
    Aglietta M; Gavosto F
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():16-8. PubMed ID: 2653496
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current status of the clinical application of hematopoietic growth factors in oncology].
    Karthaus M; Ganser A
    Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-macrophage colony stimulating factor and interleukin 3: target cells and kinetics of response in vivo.
    Aglietta M; Pasquino P; Sanavio F; Stacchini A; Severino A; Fubini L; Morelli S; Volta C; Monteverde A; Piacibello W
    Stem Cells; 1993 Jul; 11 Suppl 2():83-7. PubMed ID: 8401260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic hormones: from cloning to clinic.
    Perrine SP; Vichinsky E; Faller DV
    Am J Pediatr Hematol Oncol; 1989; 11(3):268-75. PubMed ID: 2675659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical applications of colony-stimulating factors.
    Vadhan-Raj S
    Oncol Nurs Forum; 1989; 16(6 Suppl):21-6. PubMed ID: 2687811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.